AMENDMENT NO. 1 TO TERM LOAN AGREEMENTTerm Loan Agreement • July 1st, 2014 • Cooper Companies Inc • Ophthalmic goods • New York
This AMENDMENT NO. 1 TO TERM LOAN AGREEMENT (this “Amendment”) is entered into as of June 30, 2014 among (i) THE COOPER COMPANIES, INC., a Delaware corporation (the “Borrower”), (ii) the Lenders (defined below) executing signatures page hereto, and (iii) KEYBANK NATIONAL ASSOCIATION, as the administrative agent (the “Administrative Agent”).
Dated 1 July 2014 SALE AND PURCHASE AGREEMENT for 167,094 Ordinary Shares in the capital of Sauflon Pharmaceuticals LimitedSale and Purchase Agreement • July 1st, 2014 • Cooper Companies Inc • Ophthalmic goods
Dated 30 June 2014 SALE AND PURCHASE AGREEMENT for 10,536 Ordinary Shares, 86,557 Ordinary A Shares and 31,943 Preference Shares in the capital of Sauflon Pharmaceuticals LimitedSale and Purchase Agreement • July 1st, 2014 • Cooper Companies Inc • Ophthalmic goods
AMENDMENT NO. 3 TO CREDIT AGREEMENTCredit Agreement • July 1st, 2014 • Cooper Companies Inc • Ophthalmic goods • New York
This AMENDMENT NO. 3 TO CREDIT AGREEMENT (this “Amendment”) is entered into as of June 30, 2014 among (i) THE COOPER COMPANIES, INC., a Delaware corporation (the “Company”), (ii) COOPERVISION INTERNATIONAL HOLDING COMPANY, LP, an entity organized under the laws of England and Wales and registered in Barbados as an External Company under the laws of Barbados (the “Foreign Borrower” and together with the Company, each, a “Borrower” and collectively, the “Borrowers”), (iii) the Lenders (defined below) executing signatures page hereto, and (iv) KEYBANK NATIONAL ASSOCIATION, as the administrative agent (the “Administrative Agent”).
